PrimeRFP SCOUT · Federal Contract Recompete Brief

75H71225F80098PIMC molecular thyroid NODULE testing service — Veracyte, Inc

Veracyte, Inc holds $3.4M across 46 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent 36F79718D0524. The prior award was single-bid — competitive dynamics may favor a challenge. Recompete timing centers on the Sep 14, 2027 PoP end — agencies typically plan 12–18 months ahead.

Phoenix Area Indian Health Svc

Awarding office

Veracyte, Inc

Recipient

Sep 14, 2027

PoP end

$263K

Obligated

$657K

Potential

621511

NAICS

Q301

PSC

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Veracyte, Inc — $90

Contract facts

Federal

Contract number75H71225F80098

Also listed as36F79718D0524-75H71225F80098

AgencyPhoenix Area Indian Health Svc

Awarding officePhoenix Area Indian Health Svc

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentVeracyte, Inc

CAGE60GJ7

UEIJS7GBP6LCMN6

NAICS621511

No full NAICS 621511 intel page yet. Browse NAICS intelligence

PSCQ301

Parent IDIQ / IDV36F79718D0524

Place of performancePHOENIX AZ

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startSep 10, 2025

PoP end (current)Sep 14, 2027

PoP end (w/ options)Sep 14, 2030

Obligated$263K

Current value$263K

Potential value$657K

PIMC MOLECULAR THYROID NODULE TESTING SERVICE is a federal award for Phoenix Area Indian Health Svc held by Veracyte, Inc. Estimated value $657K ($263K obligated). Current period of performance ends Sep 14, 2027 (potential Sep 14, 2030). Last award drew 1 bidder. Place of performance: PHOENIX AZ.

PIMC MOLECULAR THYROID NODULE TESTING SERVICE

Recompete timing

Public

● Expiring in 389 days

Current PoP ends Sep 14, 2027 (389 days remaining). Agencies typically plan 12–18 months ahead — position before the PoP clock runs out.

Incumbent footprint

Public record

Veracyte, Inc — $3.4M obligated across 46 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($3.4M) · all agencies

Department of Veterans Affairs (VA)$3.1M · 91%Department of Defense (DOD)$150K · 4%Department of Health and Human Services (HHS)$131K · 4%

Open full company profile →

Related awards

Same parent · incumbent

W81K0023F0175

AFIRMA GENOMIC SEQUENCING CLASSIFIER LABORATORY TESTING

$150K

Sep 30, 2026

36C26326N0391

FY 26 TASK ORDER TO SUPPORT MINNEAPOLIS VA

$168K

Apr 30, 2027

36C26326N0393

FY26 TASK ORDER TO SUPPORT ST CLOUD VA

$112K

Apr 30, 2027

36C25722P0705

VERACYTE LAB

$451K

Aug 14, 2027

36C24723P0403

AFIRMA GSC CPT 81546 AND 0204U

$529K

Jan 31, 2028

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75H71225F80098?

75H71225F80098 (PIMC molecular thyroid NODULE testing service) is a Phoenix Area Indian Health Svc award with a potential value of $657K, currently held by Veracyte, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75H71225F80098?

Phoenix Area Indian Health Svc awarded 75H71225F80098 to Veracyte, Inc (potential $657K).

Who is the incumbent on 75H71225F80098?

Veracyte, Inc is the incumbent with $3.4M across 46 related awards in SCOUT’s public footprint. The current period of performance ends Sep 14, 2027.

When does Veracyte, Inc’s 75H71225F80098 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 14, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 24, 2026 · refreshed monthlyLatest procurement action Jun 9, 2026